newsfilter
← Latest News
Business Wire·

Imago BioSciences Reports Second Quarter 2021 Financial Results and Provides Recent Business Updates

Imago BioSciences, Inc. ("Imago") (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today reported financial results for the second quarter ended June 30, 2021 a